
|Articles|October 24, 2012
Drug resistance spurs quinolone use for UTIs
As a result of concerns about antibiotic resistance, U.S. physicians are increasingly prescribing quinolones to treat urinary tract infections.
Advertisement
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves rucaparib for chemotherapy-naïve, BRCA-mutated mCRPC
2
FDA approves flibanserin for hypoactive sexual desire disorder in postmenopausal women
3
Perioperative EV plus pembrolizumab extends survival in cisplatin-eligible MIBC
4
John Michael DiBianco, MD, outlines rationale for the SOUL trial
5

















